Safety of Neoadjuvant Bevacizumab plus Pemetrexed and Carboplatin 
in Patients with IIIa Lung Adenocarcinoma

Safety of Neoadjuvant Bevacizumab plus Pemetrexed and Carboplatin 
in Patients with IIIa Lung Adenocarcinoma

Background and objective Bevacizumab has showed its efficacy in advanced non-squamous lung cancer. The aim of this study is to assess the safety of bevacizumab plus pemetrexed and carboplatin neoadjuvant chemotherapy in patients with lung adenocarcinoma. Methods 25 patients with IIIa lung adenocarci...

Full description

Bibliographic Details
Main Authors: Songliang ZHANG, Pengfei XU, Cheng YUAN, Wei OU
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2015-06-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
Bevacizumab
Neoadjuvant chemotherapy
Safety
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2015.06.06

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2015.06.06

Similar Items